Effects of intranasal salmeterol and fluticasone given alone and in combination in persistent allergic rhinitis

Keyphrases

• Salmeterol 100%
• Fluticasone Propionate 100%
• Intranasal 100%
• Persistent Allergic Rhinitis 100%
• Nasal 33%
• Adenosine Monophosphate 25%
• Potentiation 16%
• Trial Registration 8%
• Effective Treatment 8%
• Allergy 8%
• Asthma 8%
• Placebo 8%
• Placebo-controlled 8%
• Randomized Double-blind 8%
• Anti-inflammatory Activity 8%
• Allergic Rhinitis 8%
• Immunology 8%
• β2-agonists 8%
• Airway 8%
• Mucosal Mast Cells 8%
• Nasal Symptoms 8%
• Peak Nasal Inspiratory Flow 8%
• Nasal Disease 8%
• Anti-static 8%
• American Colleges 8%
• Once-daily Regimen 8%
• Mediator Release 8%
• 4-way 8%
• First Dose 8%
• Adapter 8%
• Mast Cell Activation 8%
• Disease-specific Quality of Life 8%

Pharmacology, Toxicology and Pharmaceutical Science

• Salmeterol 100%
• Fluticasone 100%
• Perennial Rhinitis 100%
• Vasomotor Rhinitis 100%
• Adenosine Phosphate 30%
• Fluticasone Propionate 30%
• Placebo 20%
• Fluticasone Propionate Plus Salmeterol 20%
• Disease 10%
• Anti-Inflammatory Drug 10%
• Allergic Asthma 10%
• Beta 2 Adrenergic Receptor Stimulating Agent 10%
• Allergic Rhinitis 10%

Immunology and Microbiology

• Salmeterol 100%
• Fluticasone 100%
• Perennial Rhinitis 100%
• Fluticasone/Salmeterol 33%
• Fluticasone Propionate 33%
• Mast Cell 22%
• Agonist 11%
• Cell Activation 11%
• Allergic Rhinitis 11%
• Antiinflammatory Activity 11%
• Allergic Asthma 11%
• Isoetarine 11%
• Peak Nasal Inspiratory Flow 11%
• Mediator Release 11%